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Background: Femoral artery cannulation at the lower bifurcation of common femoral artery is a relative contraindication for the use of vascular 
closure devices, as such patients were excluded in the pivotal trials. The nitinol clip-based closure device (Starclose) is sometimes used in such 
patients, the efficacy and safety of which is unknown.
Methods: We evaluated consecutive patients undergoing deployment of a Starclose device following coronary procedure via the femoral artery 
approach. Quantitative femoral angiographic analyses were performed using a hand caliper. The distance of the artery puncture site from the 
bifurcation was recorded in each patient. Any arterial cannulation <=3 mm from the bifurcation was categorized as a bifurcation cannulation (as the 
outer diameter of the nitinol clip of Starclose is 4 mm).
Results: Among 1096 patients who underwent deployment of a Starclose device, 217 (20%) were within 3 mm of the bifurcation. Starclose 
deployment at the bifurcation was not associated with any significant increase in the risk of any-, major or minor vascular complications (Figure) 
compared to deployment for non-bifurcation cannulations (both for diagnostic and PCI procedures). The results were unchanged in a regression 
model adjusted for a propensity score (41 baseline covariates).
Conclusions: In select group of patients, vascular closure using a extravascular closure device (Starclose) appears to be safe even for arterial 
cannulations at or near the bifurcation.
